A Publication for the Practising Medical Specialist, Industry Executive

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. 

Stay Ahead in Medical Technology

At Medical Device News Magazine, we take pride in delivering high-quality, in-depth news. Our content goes beyond the surface, providing a comprehensive look at the trends, innovations, and breakthroughs that are shaping the future of medical technology.

In addition, we aim to offer a unique perspective on the rapidly evolving healthcare landscape. By following our news, you gain exclusive insights into industry developments, emerging technologies, and regulatory updates that impact medical devices worldwide. At the same time, you become part of a vibrant community of professionals, innovators, and thought leaders who are dedicated to advancing healthcare through cutting-edge solutions.

Furthermore, we encourage you to explore our diverse range of content, from the latest product announcements to in-depth analyses of industry trends. If our vision aligns with your objectives, we also offer opportunities for advertising and collaboration, allowing you to reach a highly engaged audience of medical technology professionals.

Stay informed, stay connected, and join us as we navigate the future of healthcare together.

Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook

Bio-Rad Launches Annexin V StarBright Conjugates for Apoptosis Detection via Flow Cytometry

“Introduction of Annexin V StarBright Dye conjugates offers customers greater choice and flexibility when detecting apoptosis in both conventional and full spectrum flow cytometry,” said Hilary Mavor, Marketing Director, Life Science Group at Bio-Rad Laboratories. “Bio-Rad has one of the most comprehensive ranges of annexin V conjugates, allowing users to follow best practice and accurately detect apoptosis with minimum spillover with their viability dyes.”

Kepler Vision Technologies Reports New Partnership

Harro Stokman, CEO of Kepler Vision Technologies says: “Working with companies like OneCo Technology provide so many benefits to not just eachother’s companies but also the patients and care workers using our products. As we continue to meet and collaborate with more innovative companies like OneCo across Europe, we can expect even better solutions to be developed.”

Clinical Trials

Peripheral Arterial Disease

BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease

Dr. Sean Lyden, Chairman of the Department of Vascular Surgery at Cleveland Clinic and National Principal Investigator of the AGILITY Study said, “When we’re addressing advanced peripheral arterial disease, a self-expanding covered stent can play an important role. We need a stent that can track to the lesion, apposes the vessel wall and ultimately provides long-term durability. We’re excited to see how this technology performs.” 

Argonne Uncovers Insights About Prostate Cancer Risk and Genetic Ancestry

The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.

Biotechnology News

Alchemab advances a novel antibody with potential in Parkinson’s disease with support from The Michael J. Fox Foundation

The grant was awarded through MJFF’s Parkinson’s Disease Therapeutics Pipeline Program. The program seeks to advance testing of promising therapeutic developments that address unmet medical needs in people with PD. The program is designed to fund therapeutic development with a clear focus to prevent, stop, or delay disease progression, or to reduce the challenges of daily symptoms.

Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance

“We are thrilled with the DEA’s decision, which underscores the potential of MIRA-55 as a groundbreaking therapeutic candidate,” said Erez Aminov, Chairman & CEO of MIRA Pharmaceuticals. “This ruling allows us to focus on MIRA-55’s unique cognitive and anxiety benefits. With access to $90B traditional neurological and $30B cannabis markets, MIRA-55 represents a significant value proposition for our company.  We remain committed to advancing it through the development pipeline for treating these diseases from which so many currently suffer.”

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

Executives on the Move

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

Chamlion

Chamlion Completes 236 Million Yuan in Series B Fundraising

Chamlion notes the fundraising will be mainly used for the further expansion of the company’s domestic and overseas business, including the in-depth promotion and upgrade of their existing product line, to consolidate the company’s leading position in the field of dental digitalization.

SentiAR Series B

SentiAR Announces Close of $8.5 million Series B Financing

The financing was led by cultivate (MD) Ventures and joined by MedVenture Partners alongside several insider investors, including TechWald Holding, VCapital, QRM Capital, and Harmonix Fund. The funding will allow the company to launch additional partnerships and wider clinical deployments.

Market Reports

Advancements In Imaging

United Imaging Installs Broward County’s First uMI 550 at Holy Cross Health in Fort Lauderdale

“That mission is a draw for us because it goes hand in hand with our Core Value of ‘Reverence for Each Person,’ said Mark Doyle, President and CEO of Holy Cross Health. “We feel strongly, as United Imaging does, that every individual should have access to an equal standard of care. In addition, we have an active commitment to investing in new technologies to improve diagnosis and treatment, so our purchase of the uMI 550 is emblematic of that.”

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare: Understanding the Business Side of the Industry and Its Implications

Lab Processes

6 Ways to Streamline Lab Processes

Laboratories are increasingly focusing on efficiency and automation. The American Association for Clinical Chemistry (AACC) notes that over 4,000 labs globally have adopted automated systems,

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.